The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study

A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy

(2014) Ken Iwata et al.   BONE

Atypical femoral fractures bilaterally in a patient receiving denosumab

(2013) Efstathios Drampalos et al.   Acta Orthopaedica

Osteoclast-Derived Coupling Factors in Bone Remodeling

(2013) Kim Henriksen et al.   CALCIFIED TISSUE INTERNATIONAL

Stimulation of Bone Formation in Cortical Bone of Mice Treated with a Receptor Activator of Nuclear Factor-κB Ligand (RANKL)-binding Peptide That Possesses Osteoclastogenesis Inhibitory Activity

(2013) Yuriko Furuya et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Atypical Femoral fractures: A Review of the Literature

(2013) Pingal A. Desai et al.   Current Osteoporosis Reports

Peptide-based delivery to bone

(2012) Kazuhiro Aoki et al.   ADVANCED DRUG DELIVERY REVIEWS

Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee

(2012) David W Dempster et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bench to bedside: elucidation of the OPG–RANK–RANKL pathway and the development of denosumab

(2012) David L. Lacey et al.   NATURE REVIEWS DRUG DISCOVERY

Bone turnover markers: use in osteoporosis

(2012) Kim Naylor et al.   Nature Reviews Rheumatology

Effect of sympathetic nervous activity on alveolar bone loss induced by occlusal hypofunction in rats

(2011) Yasuhiro Shimizu et al.   ARCHIVES OF ORAL BIOLOGY

RANKL reverse signaling triggers RANKL translocation via mTORC2 activation

(2011) M. Honma⁎ et al.   BONE

Quantitative and Qualitative Analyses of Low-mineral-diet Ovariectomised Rat Femora Using Microscopic Computed Tomography

(2011) Hiroshi Nakada et al.   Journal of Hard Tissue Biology

Chondroprotective effect of alendronate in a rabbit model of osteoarthritis

(2011) Takaaki Shirai et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: Meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons

(2010) Niels Graudal et al.   ARTHRITIS AND RHEUMATISM

Denosumab and bisphosphonates: Different mechanisms of action and effects

(2010) Roland Baron et al.   BONE

Suppression of NF-κB Increases Bone Formation and Ameliorates Osteopenia in Ovariectomized Mice

(2010) Neil Alles et al.   ENDOCRINOLOGY

Are Osteoclasts Needed for the Bone Anabolic Response to Parathyroid Hormone?

(2010) Dominique D. Pierroz et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Guidelines for assessment of bone microstructure in rodents using micro-computed tomography

(2010) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates

(2009) R. K. Dore et al.   ANNALS OF THE RHEUMATIC DISEASES

Polysaccharide nanogel delivery of a TNF-α and RANKL antagonist peptide allows systemic prevention of bone loss

(2009) Neil Alles et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility

(2009) Matthijs P Somford et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Intermittent PTH Administration Stimulates Pre-Osteoblastic Proliferation Without Leading to Enhanced Bone Formation in Osteoclast-Lessc-fos−/−Mice

(2009) Paulo Henrique Luiz de Freitas et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vps33a Mediates RANKL Storage in Secretory Lysosomes in Osteoblastic Cells

(2009) Yoshiaki Kariya et al.   JOURNAL OF BONE AND MINERAL RESEARCH